Page last updated: 2024-10-29

isocarboxazid and Cerebral Palsy

isocarboxazid has been researched along with Cerebral Palsy in 1 studies

Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)

Cerebral Palsy: A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Paasonen, MK1
Solatunturi, E1
Kivalo, E1

Other Studies

1 other study available for isocarboxazid and Cerebral Palsy

ArticleYear
Monoamine oxidase activity of blood platelets and their ability to store 5-hydroxytryptamine in some mental deficiencies.
    Psychopharmacologia, 1964, Jul-20, Volume: 6, Issue:2

    Topics: Blood Platelets; Cerebral Palsy; Down Syndrome; Female; Humans; Iproniazid; Isocarboxazid; Male; Mon

1964